InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Smith Cynthia, Director. Insider active across 5 companies, notably Akebia Therapeutics, Inc.. Aggregated, 18 filings have been logged. History available since 2 June 2021. The latest transaction was disclosed on 11 August 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Smith Cynthia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
2,816 sharesCommon stockSEC:0001439222-26-000093:0
35,700 sharesCommon StockSEC:0001609480-26-000003:0
2,302 shares0Common stockSEC:0001439222-25-000097:0
2,120 shares0Common stockSEC:0001439222-25-000047:0
20,000 shares0Common StockSEC:0000950170-25-087010:0
35,700 shares0Common StockSEC:0001562180-25-004721:0
2,302 shares0Common stockSEC:0001439222-24-000125:0
3,388 shares0Common stockSEC:0001439222-24-000083:0
30,000 shares0Common StockSEC:0001562180-24-004909:0
20,000 shares0Common StockSEC:0000950170-24-066619:0
20,000 shares0Common StockSEC:0000950170-23-052716:0
2,302 shares0Common stockSEC:0001439222-23-000127:0
30,000 shares0Common StockSEC:0001562180-23-004955:0
15,000 shares0Common StockSEC:0000899243-22-031502:0
13,700 shares0Common StockSEC:0001562180-22-004977:0
3,333 shares@ US$38.25100.0% of flowCommon StockSEC:0001399529-21-000204:0
3,333 sharesCommon StockSEC:0001399529-21-000110:0
13,700 shares0Common StockSEC:0001562180-21-004030:0
18 of 18 declarations
About Smith Cynthia
Smith Cynthia is an Administrateur associated with Akebia Therapeutics, Inc., AGIOS PHARMACEUTICALS, INC., Spero Therapeutics, Inc., Dicerna Pharmaceuticals Inc and Agios Pharmaceuticals, INC. The record covers 18 filings in total, all within the recent sample, with transactions described as Attribution, and the date range runs from 2021-06-03 to 2026-06-23. The buy and sell amounts shown for this sample are 0 and 0 eur, and one filing dated 2021-12-29 at Dicerna Pharmaceuticals Inc shows 112521.5233965187 eur.
